Usefulness of Elobixibat in Patients With Chronic Constipation After Cholecystectomy
Cureus · 18.08.2024
DOI: 10.7759/cureus.67132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 18.08.2024. Verfasst von Yuji Sakai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Sakai Clinic, Kimitsu, JPN. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: There have been reports that elobixibat improves bowel movements in patients with chronic constipation. However, no studies have been conducted to date to examine bowel movements after the administration of elobixibat in patients with chronic constipation in terms of the presence or absence of the gallbladder. In this study, we examined the frequency of bowel movements and stool forms in patients with gallbladders and post-cholecystectomy patients before and after the administration of elobixibat for chronic constipation. METHODS: Elobixibat 10 mg was administered to treat chronic constipation in 40 patients with gallbladders and 18 patients who underwent cholecystectomy. The frequencies of bowel movements one week before and after elobixibat administration were compared between the two groups, using the Bristol Stool Form Scale (BSFS). RESULTS: No significant difference in patient background with or without cholecystectomy was noted between the groups. In patients with gallbladders, the pre-dosing mean frequency of bowel movements was 2.389 ± 0.502 with BSFS of 2.179 ± 0.721 and the post-dosing mean frequency of bowel movements was 4.308 ± 1.151 with BSFS of 3.718 ± 1.521, indicating significant improvement in bowel movements (p < 0.001). In post-cholecystectomy patients, the pre-dosing mean frequency of bowel movements was 2.389 ± 0.502 with BSFS of 2.222 ± 0.647 and the post-dosing mean frequency of bowel movements was 4.222 ± 1.734 with BSFS of 3.333±1.237, indicating significant improvement in bowel movements (p < 0.001). No significant difference in bowel movements was noted between patients with or without the gallbladder. CONCLUSIONS: Elobixibat is useful in improving the bowel movements of patients with chronic constipation. No significant difference was noted in the improvement of bowel movements due to cholecystectomy. It was suggested that even post-cholecystectomy patients could obtain therapeutic effects similar to patients with gallbladders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Sakai Clinic, Kimitsu, JPN.
- Department of Gastroenterology, Chiba Prefectural Sawara Hospital, Sawara, JPN.
- Department of Gastroenterology, Kimitsu Central Hospital, Kisarazu, JPN.
- Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, JPN.
- Department of Surgery, Kimitsu Central Hospital, Kisarazu, JPN.
- Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, JPN.
Zitieren
APA
Sakai, Y., Tsuyuguchi, T., Kumagai, J., Ohyama, H., Kaiho, T., Ohtsuka, M., & Kato, N. (2024). Usefulness of Elobixibat in Patients With Chronic Constipation After Cholecystectomy. Cureus. https://doi.org/10.7759/cureus.67132
Vancouver
Sakai Y, Tsuyuguchi T, Kumagai J, Ohyama H, Kaiho T, Ohtsuka M, et al. Usefulness of Elobixibat in Patients With Chronic Constipation After Cholecystectomy. Cureus. 2024. doi:10.7759/cureus.67132
BibTeX
@article{Sakai2024,
author = {Sakai, Yuji and Tsuyuguchi, Toshio and Kumagai, Junichiro and Ohyama, Hiroshi and Kaiho, Takashi and Ohtsuka, Masayuki and Kato, Naoya},
title = {Usefulness of Elobixibat in Patients With Chronic Constipation After Cholecystectomy},
journal = {Cureus},
year = {2024},
doi = {10.7759/cureus.67132}
}
EUVIMED